ReviewCancer immunology, immunotherapy : CII1986
Immune surveillance and natural resistance: an evaluation.
Review in Cancer immunology, immunotherapy : CII, 1986. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- An explanation for the worsened prognosis in some cancer patients of perioperative transfusion: the time-dependent release of biologically active growth factors from stored blood products.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2011Article
- New insights into tumor-host interactions in lymphoma metastasis.Journal of molecular medicine (Berlin, Germany) · 1996Review
- Modulation of the immune response to tumors by a novel synthetic compound, (4R)-3-benzoyl-N-[(1R)-1-phenylethyl]-4-thiazolidinecarboxamide (RS-0481).Cancer immunology, immunotherapy : CII · 1991Article
- The antitumor effects of locally injecting human peripheral blood mononuclear cells treated with OK-432 into the tumor site: the possible role of a tumor growth inhibitory factor (TGIF).The Japanese journal of surgery · 1990Article
- Common variable immunodeficiency and malignancy: a report of two cases and possible explanation for the association.Cancer immunology, immunotherapy : CII · 1990Article
- Increased bleomycin-induced chromosome damage in lymphocytes of patients with common variable immunodeficiency indicates an involvement of chromosomal instability in their cancer predisposition.Cancer immunology, immunotherapy : CII · 1989Article
- Comparison of excision versus cryosurgery of an HSV-2-induced fibrosarcoma. I. Survival, extent of metastatic disease and host immunocompetence following surgery.Cancer immunology, immunotherapy : CII · 1988Article
- Lack of a relationship between immune function and chemically induced hepatocarcinogenesis in B6C3F1 mice.Cancer immunology, immunotherapy : CII · 1988Article
- T-cell surface molecules involved in the induction and expression of lymphokine-activated killing of autologous and allogeneic tumor targets.Journal of clinical immunology · 1987Article
- [New knowledge on immunology in gynecologic cancer].Archives of gynecology and obstetrics · 1987Review
- Immune surveillance and natural resistance: an evaluation.Cancer immunology, immunotherapy : CII · 1986Article
- The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice.Cancer immunology, immunotherapy : CII · 1986Article
- A survey of some formal models in tumor immunology.Cancer immunology, immunotherapy : CII · 1986Article
- Incidence and growth of methylcholanthrene-induced tumors in mice with altered immunological status.Cancer immunology, immunotherapy : CII · 1986Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Concepts in tumour immunology are changing fundamentally. Around 1970 tumour immunology contained the following related concepts: Thousands of tumour cells arise de novo each day. Tumour cells are antigenic in their host. All these antigenic tumour cells are killed by a strong immune surveillance system. A more likely set of concepts looks as follows: Tumour cells do not arise frequently. Tumour cells may be antigenic or not. There is no need to postulate a very strong immune surveillance or natural resistance system. In this paper I am reviewing our present knowledge of immune surveillance and natural resistance. Only scanty information appears to be available. This information suggests that virally induced tumours are usually killed by cytotoxic T lymphocytes, and natural killer cells, whereas immune surveillance and natural resistance against other tumours may be quite weak.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.